Client News
Filter by:
- Oct 23 2023 Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
- Oct 19 2023 Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology
- Oct 19 2023 Zevra Therapeutics Celebrates and Supports Global Niemann-Pick Disease Awareness Day on October 19th and Niemann-Pick Disease Awareness Month Throughout October
- Oct 17 2023 Kineta Announces First Patient Dosed in Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
- Oct 16 2023 BRAEMAR HOTELS & RESORTS ANNOUNCES DATE CHANGE FOR THIRD QUARTER EARNINGS RELEASE AND CONFERENCE CALL
- Oct 16 2023 ASHFORD ANNOUNCES DATE CHANGE FOR THIRD QUARTER EARNINGS RELEASE AND CONFERENCE CALL
- Oct 16 2023 ASHFORD TRUST ANNOUNCES DATE CHANGE FOR THIRD QUARTER EARNINGS RELEASE AND CONFERENCE CALL
- Oct 16 2023 Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium
- Oct 14 2023 Cogent Biosciences Presents Preclinical Data Highlighting Precision Oncology Pipeline at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Oct 13 2023 Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial